Vast inks PGM deal with Swiss firm
The estimated sales value, based on seller assays, is expected to exceed US$100 million.
By Mthandazo Nyoni
Jan. 23, 2024
Premium
Buried in paperwork: How DNA delays are denying the dead dignity and closure
News
Aug. 2, 2026
Premium
Ncube’s budget squeezes under-pressure firms
Business
By Tatira Zwinoira and Blessed Ndlovu
Aug. 2, 2026




